ライフサイエンスコーパス: displaceable

1 majority (94%) of the binding was specific (displaceable).

2 hat are metastable, but easily reversible or displaceable.

3 heme-iron residues in EcDos must be readily displaceable.

4 5-HT-displaceable [125I]3beta-(4-iodophenyl)-tropane-2beta-ca

5 lon2 subunit correlated with changes in NMDA-displaceable [(3)H]glutamate binding, and mRNA density c

6 However, picrotoxin displaceable [(35)S]TBPS binding to alpha1beta2gamma2 GA

7 glutamate recognition site by specific NMDA-displaceable [3H]glutamate binding assays.

8 NMDA-displaceable [3H]glutamate binding was markedly increase

9 Imipramine-displaceable 5-[3H]HT binding to intact L-S1 cells was s

10 nabled quantitative assessment of imipramine-displaceable 5-[3H]HT binding to the 5-HT transport syst

11 Although 12 and 13 showed displaceable and specific binding to Y(1)R in vitro and

12 All brain regions exhibited displaceable and specific binding, and thus none could b

13 he interaction of PIB with CAA was not fully displaceable and this may be linked to the apolipoprotei

14 Tracer binding showed saturable, displaceable, and uneven distribution in rat brain slice

15 Binding potentials relative to non-displaceable binding (BPND) for [(11)C]carfentanil and i

16 1)C-IMA107 binding potential relative to non-displaceable binding (BPND) were generated from the dyna

17 mal tissues, coupled with the high degree of displaceable binding from both tumors and the normal bra

18 mation of the binding parameters due to high displaceable binding in the reference region.

19 (3)H-MK-6240 showed no displaceable binding in the subcortical regions of human

20 Displaceable binding matching MOR distribution in the br

21 Displaceable binding of (11)C-DASB was found in all brai

22 human erythrocytes, and blocked the glucose-displaceable binding of cytochalasin B to GLUT1 in eryth

23 dies showed that genistein inhibited glucose-displaceable binding of cytochalasin B to GLUT1 in eryth

24 oligand binding analyses showed specific and displaceable binding of MIP-1beta to thymocytes with a K

25 s controls showed a higher (11)C-PK11195 non-displaceable binding potential (BP(ND)) (d = 0.45).

26 MOR non-displaceable binding potential (BP(ND)) was measured in

27 Non-displaceable binding potential (BPND) in 43 brain region

28 3T SNCA carriers had loss of [(11)C]DASB non-displaceable binding potential in brain areas correspond

29 n's disease had decreases in [(11)C]DASB non-displaceable binding potential in brain areas correspond

30 se as seed maps to calculate [(11)C]DASB non-displaceable binding potential in our cohort of A53T SNC

31 Decreases in [(11)C]DASB non-displaceable binding potential in the brainstem were ass

32 SNCA carriers showed loss of [(11)C]DASB non-displaceable binding potential in the ventral (p<0.0001)

33 ansporter availability was quantified as non-displaceable binding potential using a kinetic model for

34 to Braak stages 1-3, whereas [(11)C]DASB non-displaceable binding potential was largely preserved in

35 learly elevated binding potential (BPND (non-displaceable binding potential)) in temporal lobes, late

36 D(2)R availability (non-displaceable binding potential; BP(ND)) was measured pre

37 lation between 11C-UCB-J and 18F-AV-1451 non-displaceable binding potentials (beta = 0.4, t = 3.6, P

38 upranuclear palsy rating scale; regional non-displaceable binding potentials of 11C-UCB-J and 18F-AV-

39 btaining putamen and caudate specific to non-displaceable binding ratios (SBRs).

40 es were present, we used [(11)C]DASB PET non-displaceable binding to quantify serotonin transporter d

41 man Alzheimer's disease brains showed highly displaceable binding to tau-rich regions.

42 In rats, displaceable binding was largely reduced in the cerebell

43 No displaceable binding was observed in self-block studies

44 3, namely, reasonable brain permeability and displaceable binding.

45 with 7d reduced whole-brain AUC, indicating displaceable binding.

46 confirmed that the brain had specific (i.e., displaceable) binding but could not detect specific bind

47 pectively, and these repressor complexes are displaceable by E2F-1.

48 2 receptors was saturable (KD = 0.15 nM) and displaceable by galanin peptides and analogues in rank o

49 rat KD = 0.98 nM and human KD = 2.23 nM) and displaceable by galanin peptides and analogues in the fo

50 g of [(3)H]38 was fully reversible and fully displaceable by nonpeptide antagonists and the agonist p

51 that [3H]-L-685,458 binding was saturatable, displaceable by peptidomimetic and small molecule gamma-

52 sections (but not WAT) in vitro was high and displaceable by pretreatment with rimonabant.

53 HNF-4alpha with intact F-domain was readily displaceable by S-hexadecyl-CoA, a nonhydrolyzable thioe

54 I binding to TE671 cell homogenates is fully displaceable by the small molecule antagonist d-tubocura

55 C cells at 0.02-20 nM concentrations and was displaceable by TSP-1.

56 which is reversibly bound to this enzyme and displaceable by tyramine, will be an antidepressant whic

57 anism that considers the effect of stable vs displaceable coatings during NP migration in CE is sugge

58 e measured binding potential relative to non-displaceable compartment (BPND) and derived percent redu

59 greater Q(10) (27-37 degrees C) than the non-displaceable component

60 C]PHNO binding potential relative to the non-displaceable component (BP(ND)) in all regions examined

61 s using positron emission tomography and the displaceable D(2)/D(3) receptor radiotracer [(11)C]raclo

62 s in high yield and purity using selectively displaceable DNA linkers.

63 in these DAT-rich regions was significantly displaceable either by preadministration of citalopram f

64 agnetic and electric field, respectively-use displaceable fluids to establish relatively large temper

65 1,3,4,5)P4, showed specific, PtdIns(3,4,5)P3-displaceable labeling of only alpha-COP.

66 -2-linked [3H]BZDC-IP6 showed efficient, IP6-displaceable labeling of the GST-Syt II-C2B.

67 croM) did not reduce dextromethorphan (1 mM)-displaceable ligand binding.

68 stimate of the volume of distribution of non-displaceable ligand in brain tissue that increased with

69 lls in a dose-dependent, saturable, and self-displaceable manner.

70 Confocal microscopy revealed clear, displaceable membrane labeling of CHO-A(3) cells with 19

71 hodology for the fabrication of controllably displaceable monolayers using a carboxyl-functionalized

72 sufficiently separated conserved waters from displaceable or absent ones.

73 Highly selective Ins(1,3,4,5)P4-displaceable photocovalent modification of the alpha-COP

74 Recently reported "displaceable probe" loop amplification (DP-LAMP) archite

75 ment study for the other enantiomer found no displaceable radioactivity in the same group of mice; th

76 The displaceable radioactivity of one enantiomer in the brai

77 nance spectroscopies about the nature of the displaceable residue in the heme-PAS domain of EcDos, i.

78 s a high affinity (K(d) = 30 nM), saturable, displaceable, single binding site specific for progestin

79 Induction of displaceable soluble FN binding correlates with the abil

80 lsilane stationary phases using octanol as a displaceable surface template to control the rate of alk

81 ical for binding, the methionines are easily displaceable to increase the accessibility of these resi

82 se patients with [(18)F]FEM-IMPY showed high displaceable uptake in gray matter and low nonspecific b

83 ter of typically below 100 nm and are easily displaceable using an electrical current of 10(2) A/cm(2

84 riments showed that the binding to BVECs was displaceable, was saturable, and yielded a typical bindi

85 ons of high SERT density of monkey brain was displaceable with citalopram except in the putamen and c

86 ulation of [123I]IACFT was nearly completely displaceable with unlabeled CFT (1 mg/kg) but was not af

87 macromolecules was specific, reversible, and displaceable with unlabeled leptin (ED50: 0.73 +/- 0.09

88 binding was specific for progestins and was displaceable, with rapid rates of association and dissoc